Rein Therapeutics (RNTX) Current Assets (2016 - 2026)
Rein Therapeutics (RNTX) recorded Current Assets of $41.45 million in Q2 2026, up 527.9% from $6.6 million a year earlier and up 660.2% from the prior quarter.
Powered by 
Analysis
Rein Therapeutics (RNTX) Current Assets (2016 - 2026) Analysis & Trends
At the end of FY2025, Rein Therapeutics reported Current Assets of $4.33 million, down 68.3% from FY2024.
- Annual Current Assets has declined for four straight years, with a five-year compound annual growth rate of -23.3% (FY2020 to FY2025).
- Across earlier years, Current Assets came in at $13.66 million in FY2024 (-25.2%), $18.27 million in FY2023 (-16.5%), $21.87 million in FY2022 (-54.6%) and $48.18 million in FY2021 (+195.1%).
- The Q2 2026 figure is the highest quarterly Current Assets since Q4 2021.
- On a year-over-year basis, Current Assets rose in two of the last eight quarters, with growth averaging 33.4%.
- Peak year-over-year performance for Current Assets in the last five years was growth of 527.9% in Q2 2026, against a decline of 72.3% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $5.45 million (Q1 2026), $4.33 million (Q4 2025) and $5.17 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Rein Therapeutics | 48.30 Mn | 48.30 Mn | - | 41.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.45 Mn |
| Mar 31, 2026 | 5.45 Mn |
| Dec 31, 2025 | 4.33 Mn |
| Sep 30, 2025 | 5.17 Mn |
| Jun 30, 2025 | 6.60 Mn |
| Mar 31, 2025 | 8.33 Mn |
| Dec 31, 2024 | 13.66 Mn |
| Sep 30, 2024 | 18.68 Mn |
| Jun 30, 2024 | 23.16 Mn |
| Mar 31, 2024 | 12.76 Mn |
| Dec 31, 2023 | 18.27 Mn |
| Sep 30, 2023 | 12.79 Mn |
| Jun 30, 2023 | 13.95 Mn |
| Mar 31, 2023 | 17.11 Mn |
| Dec 31, 2022 | 21.87 Mn |
| Sep 30, 2022 | 27.05 Mn |
| Jun 30, 2022 | 33.55 Mn |
| Mar 31, 2022 | 39.99 Mn |
| Dec 31, 2021 | 48.18 Mn |
| Sep 30, 2021 | 54.42 Mn |
API Access
Rein Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=RNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "RNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=RNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();